Sterubin

The marquee application and the reason the page matters. Sterubin was identified from Eriodictyon californicum as the single active in a battery of old-age/AD-relevant phenotypic assays (oxytosis, ferroptosis, ATP depletion, trophic-factor withdrawal, intracellular amyloid), shown to be a potent neuroprotectant and anti-inflammatory ^{1Reference 1Fischer W et al. · 2019Old-age-associated phenotypic screening for Alzheimer’s disease drug candidates identifies sterubin as a potent neuroprotective compound from yerba santaView study →}; a structure-activity follow-up found it out-performed seven related flavonoids and prevented decreases in short- and long-term memory in a short-term AD mouse model, correlating with strong Nrf2 induction ^{2Reference 2Liang Z et al. · 2022Structural requirements for the neuroprotective and anti-inflammatory activities of the flavanone sterubinView study →}, with the natural (2S) enantiomer confirmed active ^{3Reference 3Hofmann J et al. · 2020In vitroSterubin: enantioresolution and configurational stability, enantiomeric purity in nature, and neuroprotective activity in vitro and in vivoView study →} and independent rat AD ^{6Reference 6Kazmi I et al. · 2023AnimalSterubin protects against chemically-induced Alzheimer’s disease by reducing biomarkers of inflammation (IL-6/IL-1β/TNF-α) and oxidative stress (SOD/MDA) in ratsView study →} and Parkinson’s ^{7Reference 7Alqurashi GK et al. · 2024Protective effect of sterubin against neurochemical and behavioural impairments in rotenone-induced Parkinson’s diseaseView study →} models supporting it.

Gap: entirely preclinical — cell assays plus short-term rodent models, with no chronic transgenic-AD study and no human data of any kind ^{1,2Reference 1Fischer W et al. · 2019Old-age-associated phenotypic screening for Alzheimer’s disease drug candidates identifies sterubin as a potent neuroprotective compound from yerba santaView study →Reference 2Liang Z et al. · 2022Structural requirements for the neuroprotective and anti-inflammatory activities of the flavanone sterubinView study →}.

Sterubin suppresses inflammatory activation in LPS-stimulated brain microglia and lowers pro-inflammatory cytokines (IL-6/IL-1β/TNF-α) in vivo ^{2,5,6Reference 2Liang Z et al. · 2022Structural requirements for the neuroprotective and anti-inflammatory activities of the flavanone sterubinView study →Reference 5Maher P et al. · 2020The value of herbarium collections to the discovery of novel treatments for Alzheimer’s disease, a case made with the genus EriodictyonView study →Reference 6Kazmi I et al. · 2023AnimalSterubin protects against chemically-induced Alzheimer’s disease by reducing biomarkers of inflammation (IL-6/IL-1β/TNF-α) and oxidative stress (SOD/MDA) in ratsView study →}; the anti-inflammatory and neuroprotective activities co-segregate and both track Nrf2 induction in nerve and microglial cells ^{2Reference 2Liang Z et al. · 2022Structural requirements for the neuroprotective and anti-inflammatory activities of the flavanone sterubinView study →}.

Gap: cell and rodent only, with no isolated-compound clinical anti-inflammatory data ^{5Reference 5Maher P et al. · 2020The value of herbarium collections to the discovery of novel treatments for Alzheimer’s disease, a case made with the genus EriodictyonView study →}.

Sterubin is a strong inhibitor of the oxytosis/ferroptosis axis (an iron-dependent lipid-peroxidation death pathway) ^{1,5Reference 1Fischer W et al. · 2019Old-age-associated phenotypic screening for Alzheimer’s disease drug candidates identifies sterubin as a potent neuroprotective compound from yerba santaView study →Reference 5Maher P et al. · 2020The value of herbarium collections to the discovery of novel treatments for Alzheimer’s disease, a case made with the genus EriodictyonView study →}, activates Nrf2 ^{2Reference 2Liang Z et al. · 2022Structural requirements for the neuroprotective and anti-inflammatory activities of the flavanone sterubinView study →}, and maintains mitochondrial redox, calcium handling and bioenergetics under oxytotic/ferroptotic stress — though mitochondria are not required for its protection, indicating multiple parallel targets ^{4Reference 4Goujon M et al. · 2024The neuroprotective flavonoids sterubin and fisetin maintain mitochondrial health under oxytotic/ferroptotic stress and improve bioenergetic efficiency in HT22 neuronal cellsView study →}.

Gap: iron chelation is inferred from the ferroptosis-inhibition mechanism and catechol chemistry rather than a dedicated sterubin metal-binding assay, and all data are in-vitro ^{1,4Reference 1Fischer W et al. · 2019Old-age-associated phenotypic screening for Alzheimer’s disease drug candidates identifies sterubin as a potent neuroprotective compound from yerba santaView study →Reference 4Goujon M et al. · 2024The neuroprotective flavonoids sterubin and fisetin maintain mitochondrial health under oxytotic/ferroptotic stress and improve bioenergetic efficiency in HT22 neuronal cellsView study →}.

A single dermatology study reported that sterubin (from E. angustifolium) reduces human hair greying ^{9Reference 9Taguchi N et al. · 2018Reduction in human hair greying by sterubin, an active flavonoid of Eriodictyon angustifoliumView study →}, and several network-pharmacology/docking exercises predict Alzheimer’s targets ^{10Reference 10Ahmad SS et al. · 2024From network pharmacology to molecular-docking analysis of sterubin targets for Alzheimer’sView study →}.

Gap: the cosmetic finding is single-group, on a different Eriodictyon species, and the docking work is non-experimental — hypothesis, not evidence ^{9,10Reference 9Taguchi N et al. · 2018Reduction in human hair greying by sterubin, an active flavonoid of Eriodictyon angustifoliumView study →Reference 10Ahmad SS et al. · 2024From network pharmacology to molecular-docking analysis of sterubin targets for Alzheimer’sView study →}.